Navigation Links
72 new members chosen by Academy
Date:4/29/2008

ETH A.; professor of pharmaceutical chemistry, biochemistry, and biophysics, department of pharmaceutical chemistry, University of California, San Francisco

FULLER, MARGARET T.; Reed-Hodgson Professor in Human Biology and professor of genetics, department of developmental biology, Stanford University School of Medicine, Stanford, Calif.

GEISLER, WILSON S.; professor of psychology and biomedical engineering and David Wechsler Regents Chair, department of psychology, University of Texas, Austin

GREENBERG, MICHAEL E.; professor, departments of neurology and neurobiology, Harvard Medical School, and director, division of neuroscience, Children's Hospital, Boston

GRUNSTEIN, MICHAEL; professor of biological chemistry, department of biological chemistry, David Geffen School of Medicine, University of California, Los Angeles

GUYER, JANE I.; professor of anthropology, department of anthropology, Johns Hopkins University, Baltimore

HERNQUIST, LARS E.; professor, Harvard-Smithsonian Center for Astrophysics, Cambridge, Mass.

HILLIS, DAVID M.; director, center for computational biology and bioinformatics, and Roark Centennial Professor, University of Texas, Austin

HOFER, HELMUT; professor, Courant Institute of Mathematical Sciences, New York University, New York City

HU, EVELYN L.; professor, electrical and computer engineering department, University of California, Santa Barbara

JACOBSEN, ERIC N.; Sheldon Emery Professor of Chemistry, department of chemistry and chemical biology, Harvard University, Cambridge, Mass.

JENKINS, NANCY A.; deputy director and principal investigator, cell cycle control, Institute of Molecular and Cell Biology, Proteos, Singapore

JONES, PETER WILCOX; professor, department of mathematics, Yale University, New Haven, Conn.

KASTNER, MARC A.; Donner Professor and dean of science, School of Science, Massachusetts Institute of Technology, Camb
'/>"/>

Contact: Maureen O'Leary
news@nas.edu
202-334-2138
The National Academies
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8

Related biology news :

1. Entomological Society of America recognizes 2007 fellows and honorary members
2. University of Pennsylvania researchers zero in on the tiniest members in the war on cancer
3. Midlands Consortium delighted to be chosen to host £1 billion energy institute
4. Academy volunteer wins national paleontology award
5. Academy honors 13 for major contributions to science
6. Academy establishes Asia Center to protect the environment
7. Nobel laureate Dr. Linda Buck elected to American Academy of Arts & Sciences 2008 Class of Fellows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Fla. When treating devastating brain diseases such as ... bags to find something to help a patient. , ... help the vast majority of patients with ataxia ... coordination. , University of Florida neurologists are trying to ... Challenge grant from the National Institute of Neurological Disorders ...
(Date:12/15/2009)... environmental impacts, social dynamics, and production levels are ... of an agroecosystem. Positive or negative, these factors ... social groups to continuously adapt farming and food ... learning theory suggests that knowledge is gained as ... are especially valuable for environmental and agricultural educators ...
(Date:12/15/2009)... December 2009 - Scientists at VIB and Ghent University ... the treatment of septic shock, the major cause of ... of nitric oxide (NO) gas in mice with septic ... the animal,s organs showed much less damage, while their ... expectations, since it is generally assumed that nitric oxide ...
Breaking Biology News(10 mins):UF to lead national effort to help patients with rare brain disease 2UF to lead national effort to help patients with rare brain disease 3Experiential learning teaches change and adaptation 2Septic shock: Nitric oxide beneficial after all 2First Potential Lupus Specific Treatment in Sight 4744 1First Potential Lupus Specific Treatment in Sight 4744 2First Potential Lupus Specific Treatment in Sight 4744 3Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA 28TM 29 in Systemic Lupus Erythematosus 4741 1Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA 28TM 29 in Systemic Lupus Erythematosus 4741 2Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA 28TM 29 in Systemic Lupus Erythematosus 4741 3Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA 28TM 29 in Systemic Lupus Erythematosus 4741 4Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA 28TM 29 in Systemic Lupus Erythematosus 4741 5Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA 28TM 29 in Systemic Lupus Erythematosus 4741 6Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA 28TM 29 in Systemic Lupus Erythematosus 4741 7Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA 28TM 29 in Systemic Lupus Erythematosus 4741 8Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA 28TM 29 in Systemic Lupus Erythematosus 4741 9Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA 28TM 29 in Systemic Lupus Erythematosus 4741 10Waging War on Wrinkles 3A Infini Cosmetic Associates Now Offers Recent FDA Approved Dysport The Botox Alternative 52054 1Waging War on Wrinkles 3A Infini Cosmetic Associates Now Offers Recent FDA Approved Dysport The Botox Alternative 52054 2
... EPA,s ocean survey vessel, the OSV BOLD, will conduct a series ... in and around the San Juan Bay Estuary, Jobos Bay, La ... also be open to the public when it docks in San ... Feb. 23, the OSV BOLD will sail to the U.S. Virgin ...
... read stories about how to "grow your own organs" using ... this breakthrough has been elusive. A new report published in ... ( http://www.fasebj.org ) brings bioengineered organs a step closer, as ... describe how they were able to use a "scaffolding" material ...
... WASHINGTON, D.C. Neuroscientists at Georgetown University Medical Center ... looks like when someone anticipates an action or sensory ... issue of the Journal of Neuroscience , they ... of the brain responsible for preparing the body to ...
Other Biology News:EPA to study Puerto Rico waters and marine habitat 2From stem cells to new organs: Stanford and NYU scientists cross threshold in regenerative medicine 2Researchers capture wave of brain activity linked to anticipation 2
(Date:12/15/2009)... Reportlinker.com announces that a new market research ... The Future of Orphan Diseases ... Analysis and Reimbursement ,, ... Summary ,, The author has released ... Diseases Therapeutics - Market Forecasts to 2015, ...
(Date:12/15/2009)... Minn., Dec. 15 The Mosaic Company (NYSE: ... fiscal year 2010 earnings results and financial tables on ... on the New York Stock Exchange. Results will ... ,, The Company will host a conference call with ... the results. The call will begin at 11:00 ...
(Date:12/15/2009)... PHILADELPHIA and LONDON, Dec. 15 ... Thomson Pharma ® has become the first ... trial protocol and outcome information. This highly anticipated ... Pharma customers this month. ,, ... trial intelligence from registries, publications, press releases, conferences, ...
(Date:12/14/2009)... -- Vermillion, Inc. (Pink Sheets: VRML), a ... Wallen, Ph.D. Chief Scientific Officer, Senior Vice ... will be joining its board of directors ... ,, "Bill brings more than 20 years ... biotechnology," said Gail Page, Vermillion Executive Chairperson. ...
Breaking Biology Technology:Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 2Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 3Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 4Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 5Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 6Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 7Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 8Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 9Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 10Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 11Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 12Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 13Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 14Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 15Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 16Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 17Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 18Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call 2Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4
... Following the,completion of the Phase II clinical development of ... end of Phase,II meeting with the FDA to discuss ... there was an open and highly constructive discussion with ... the first ever formal discussions with the,agency to license ...
... Holmes Named PartnerLONDON, March 3 Index Ventures ... stage fund, Index Ventures V. The fund is dedicated ... and clean technology sectors across Europe, the United States and ... has raised in the past ten years and reinforces the ...
... Stock Exchange Symbol: MSEDMONTON, March 2 /PRNewswire-FirstCall/ - BioMS ... treatment of multiple sclerosis (MS), announced that effective on ... purchase warrants, each of which entitles the holder to ... of $5.00 per share, will be extended from March ...
Other Biology Technology:Bavarian Nordic Has Essentially Agreed a Pathway for the Licensure of IMVAMUNE(R) With the FDA After Successful End of Phase II Meeting 2Bavarian Nordic Has Essentially Agreed a Pathway for the Licensure of IMVAMUNE(R) With the FDA After Successful End of Phase II Meeting 3Index Ventures Closes Euro 350 Million Early Stage Fund 2BioMS Medical warrant extension 2
Fingerprinting II Informatix cluster analysis is an optional module that adds dendrogram and phylogenetic tree construction, cluster and group significance, and congruence of techniques functions to ...
... II identification and library ... module that adds capabilities ... and identification of unknowns ... entries of the same ...
Fingerprinting II Informatix optional matrix types module, is an optional module that adds external similarity and distance matrix functions to the Fingerprinting II Informatix software package....
... Zyagen tissue microarrays are derived from ... to rigorous quality control procedures to ensure ... are manually assembled in one block, sectioned ... mounted on coated slides. Sections are large ...
Biology Products: